Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth

xmlui.dri2xhtml.structural.head-subtitle

K-REx will undergo a system upgrade on Tuesday, February 16.

This item appears in the following Collection(s)